Academic Journal
A framework for monitoring RSV prevention product effectiveness in the United States.
| العنوان: | A framework for monitoring RSV prevention product effectiveness in the United States. |
|---|---|
| المؤلفون: | Roper, Lauren E, Link-Gelles, Ruth, Surie, Diya, DeCuir, Jennifer, Zambrano, Laura D, Prill, Mila M, Havers, Fiona P, Jones, Jefferson M, Melgar, Michael, Hall, Aron J, Whitehead, Ralph D, McMorrow, Meredith L, Ioannou, George N, Hernandez-Romieu, Alfonso C, Britton, Amadea, Novosad, Shannon, Martin, Abby, Feldstein, Leora R, Bajema, Kristina L, Kirking, Hannah, Moline, Heidi, Campbell, Angela P, Aslan, Mihaela, Hatfield, Kelly, Dawood, Fatimah, Slayton, Rachel, Reddy, Sujan, Gomes, Danica, Fleming-Dutra, Katherine E, Payne, Amanda B |
| المصدر: | Vaccine ; ISSN:1873-2518 ; Volume:45 |
| بيانات النشر: | Elsevier Science |
| سنة النشر: | 2025 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | Effectiveness, Immunization, Respiratory syncytial virus |
| الوصف: | During 2023, the Centers for Disease Control and Prevention (CDC) recommended the first respiratory syncytial virus (RSV) immunizations intended for widespread use in the United States to prevent severe RSV illness in infants and older adults. CDC, in collaboration with federal, public health, and academic partners, is conducting evaluations of real-world effectiveness of recommended RSV immunization products in the United States. Similar frameworks for evaluation are being applied to RSV vaccines and nirsevimab, a long-acting preventative monoclonal antibody, to estimate product effectiveness. The overall goal of CDC's RSV immunization effectiveness program is to generate timely and robust evidence through observational studies to inform immunization product policy decisions and other measures related to RSV prevention and control. CDC is evaluating effectiveness through high-quality, well-controlled observational studies leveraging a variety of platforms that provide robust data to inform policy decisions. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | https://doi.org/10.1016/j.vaccine.2024.126633; https://pubmed.ncbi.nlm.nih.gov/39755055 |
| DOI: | 10.1016/j.vaccine.2024.126633 |
| الاتاحة: | https://doi.org/10.1016/j.vaccine.2024.126633 https://pubmed.ncbi.nlm.nih.gov/39755055 |
| Rights: | Published by Elsevier Ltd. |
| رقم الانضمام: | edsbas.B5206004 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.vaccine.2024.126633 |
|---|